DK1060165T3 - Fremgangsmåde til fremstilling af et N-substitueret heterocyklisk derivat under anvendelse af en faseoverförselskatalysator - Google Patents

Fremgangsmåde til fremstilling af et N-substitueret heterocyklisk derivat under anvendelse af en faseoverförselskatalysator

Info

Publication number
DK1060165T3
DK1060165T3 DK99904158T DK99904158T DK1060165T3 DK 1060165 T3 DK1060165 T3 DK 1060165T3 DK 99904158 T DK99904158 T DK 99904158T DK 99904158 T DK99904158 T DK 99904158T DK 1060165 T3 DK1060165 T3 DK 1060165T3
Authority
DK
Denmark
Prior art keywords
preparing
substituted heterocyclic
phase transfer
transfer catalyst
heterocyclic derivative
Prior art date
Application number
DK99904158T
Other languages
Danish (da)
English (en)
Inventor
Jerome L Moniot
Neal G Anderson
Rajendra Deshpande
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK1060165T3 publication Critical patent/DK1060165T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99904158T 1998-01-30 1999-01-20 Fremgangsmåde til fremstilling af et N-substitueret heterocyklisk derivat under anvendelse af en faseoverförselskatalysator DK1060165T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7310398P 1998-01-30 1998-01-30
EP99904158A EP1060165B1 (de) 1998-01-30 1999-01-20 Verfahren zur herstellung eines n-substituierten heterocyclischen derivats unterverwendung eines phasentransfer-katalysators

Publications (1)

Publication Number Publication Date
DK1060165T3 true DK1060165T3 (da) 2004-11-22

Family

ID=22111745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99904158T DK1060165T3 (da) 1998-01-30 1999-01-20 Fremgangsmåde til fremstilling af et N-substitueret heterocyklisk derivat under anvendelse af en faseoverförselskatalysator

Country Status (15)

Country Link
US (1) US6162922A (de)
EP (1) EP1060165B1 (de)
JP (2) JP4441114B2 (de)
KR (1) KR100546530B1 (de)
AT (1) ATE275135T1 (de)
AU (1) AU743018B2 (de)
CA (1) CA2318791A1 (de)
DE (1) DE69919849T2 (de)
DK (1) DK1060165T3 (de)
ES (1) ES2228006T3 (de)
HU (1) HU226770B1 (de)
IL (1) IL136357A (de)
PT (1) PT1060165E (de)
TW (1) TWI229076B (de)
WO (1) WO1999038847A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU218680B (hu) * 1997-07-25 2000-10-30 Sanofi-Synthelabo Eljárás 1,3-diaza-spiro[4,4]non-1-én-4-on-származékok előállítására és 1-ciano-1-(acil-amino)-ciklopentán intermedierek
WO2004007482A2 (en) * 2002-07-16 2004-01-22 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
US20090286990A1 (en) * 2004-05-20 2009-11-19 Reguri Buchi Reddy Process for preparing irbesartan
EP1750862B1 (de) 2004-06-04 2011-01-05 Teva Pharmaceutical Industries Ltd. Irbesartan enthaltende pharmazeutische zusammensetzung
SI21848A (sl) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava seskvihidratne hidrokloridne soli tetrazolskega derivata
TWI346108B (en) * 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
WO2007013101A1 (en) * 2005-07-27 2007-02-01 Jubilant Organosys Limited PROCESS FOR PRODUCING 2-(N-BUTYL)-3-[[2'-(TETRAZOL-5-YL)BIPHENYL- 4-YL]METHYL]-l,3-DIAZASPIRO[4.4] NON-1-EN-4-ONE
EP1764365A1 (de) * 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto Verfahren zur Herstellung Sartanderivate und Zwischenprodukte für dieses Verfahren
CA2654218C (en) 2006-04-07 2014-07-22 Lek Pharmaceuticals D.D. Process for the preparation of pure irbesartan
CN100413853C (zh) * 2006-09-21 2008-08-27 浙江海正药业股份有限公司 厄贝沙坦的合成中间体及其制备方法和制备药物的用途
WO2008087401A1 (en) * 2007-01-18 2008-07-24 Rainbow Engineering Services Sulfate salts of irbesartan and their preparation and pharmaceutical compositions
US7671273B2 (en) 2007-10-09 2010-03-02 International Business Machines Corporation Method and apparatus for facilitating signal transmission using differential transmission lines
WO2010116380A2 (en) * 2009-04-08 2010-10-14 Ctx Life Sciences Pvt. Ltd. A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
CN101781287B (zh) * 2010-03-26 2013-03-20 天津大学 一种厄贝沙坦氢溴酸盐及其制备方法
CN110487931B (zh) * 2019-08-21 2024-10-01 浙江华海药业股份有限公司 一种(e)-4-苯基-4-氧代-2-丁烯酸乙酯的分析方法
WO2022094148A1 (en) * 2020-10-30 2022-05-05 Encodia, Inc. Conjugation reagents and methods using 1,2-cyclohexanediones

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
IE910913A1 (en) * 1990-03-20 1991-09-25 Sanofi Sa N-substituted heterocyclic derivates, their preparation¹and pharmaceutical compositions containing them
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
FR2673427B1 (fr) * 1991-03-01 1993-06-18 Sanofi Elf Derives heterocycliques diazotes n-substitues par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
EP0599999A1 (de) * 1991-08-19 1994-06-08 E.I. Du Pont De Nemours And Company Imidazolinon Derivate mit Angiotensin II Rezeptor Blockierungswirkung
FR2688781B1 (fr) * 1992-03-23 1994-07-01 Sanofi Elf Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
FR2689887B1 (fr) * 1992-04-13 1995-06-23 Sanofi Elf Procede de preparation d'un derive de biphenyle.
JP2707390B2 (ja) * 1992-05-22 1998-01-28 壽製薬株式会社 シクロヘプトイミダゾ−ル誘導体及びその製造方法並びにこれを含有する薬剤
US5612363A (en) * 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants

Also Published As

Publication number Publication date
CA2318791A1 (en) 1999-08-05
KR100546530B1 (ko) 2006-01-26
AU743018B2 (en) 2002-01-17
EP1060165A4 (de) 2002-07-31
HUP0100898A2 (hu) 2002-02-28
JP2010018638A (ja) 2010-01-28
WO1999038847A1 (en) 1999-08-05
EP1060165B1 (de) 2004-09-01
JP4441114B2 (ja) 2010-03-31
DE69919849T2 (de) 2005-09-22
AU2461599A (en) 1999-08-16
EP1060165A1 (de) 2000-12-20
PT1060165E (pt) 2004-12-31
ATE275135T1 (de) 2004-09-15
IL136357A (en) 2004-07-25
HUP0100898A3 (en) 2002-03-28
US6162922A (en) 2000-12-19
TWI229076B (en) 2005-03-11
HU226770B1 (en) 2009-09-28
ES2228006T3 (es) 2005-04-01
JP2002501946A (ja) 2002-01-22
KR20010034477A (ko) 2001-04-25
DE69919849D1 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
DK1060165T3 (da) Fremgangsmåde til fremstilling af et N-substitueret heterocyklisk derivat under anvendelse af en faseoverförselskatalysator
DE50001729D1 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
EE9900488A (et) Farmakoloogiliselt aktiivse aine valmistamise uus meetod
NO20025525L (no) Substituerte pyrrolpyridinonderivater, brukbare som fosfordiesterase-inhibitorer
TR199600177A2 (tr) N-(3-benzofuranil)üre türevleri.
IS4219A (is) Aðferð til framleiðslu á Indole afleiðum
DK1015466T3 (da) Derivater af 9-hydrazon og 9-azinerythromycin og en fremgangsmåde til fremstilling af samme
NO980178D0 (no) Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater
DK1222159T3 (da) Mellemprodukter til fremstilling af et benzofuran- eller benzothiophenderivat, som er nitreret i position 5, og anvendelse heraf
ATE219067T1 (de) Substituierte (2-(1-piperazinyl)ethoxy)methyl- derivate
DK1040121T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af cyclosporinderivater
ES2045485T3 (es) Metodo de preparacion de derivados de fenil-6 piperazinilalquil-3 1h, 3h-pirimidinediona-2,4, y su aplicacion en terapeutica.
DK0852580T3 (da) Fremgangsmåde til fremstilling af dihydroxypyrimidin-derivater
NO990914L (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
DK0863868T3 (da) Fremgangsmåde til fremstilling af 1-aryl-1-cyanocyclobutanderivater
DK0975594T3 (da) Fremgangsmåde til fremstilling af indolderivater
DK1228031T3 (da) Omegakædemodificerede 15-hydroxyeicosatetraensyrederivater, der er egnede til behandling af øjentørhed
NO980929D0 (no) Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse
DK0885222T3 (da) Heterocycliske ergolinderivater som 5HT1A-receptorligander
DK1113009T3 (da) Fremgangsmåde til fremstilling af sulfonylaminocarbonyltriazolinonsalte
IS5523A (is) Aðferð til að framleiða ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amín
NO912980D0 (no) Fremgangsmaate for fremstilling av 2-(9-fluorenoyl)-carbapenderivater
DK0946548T3 (da) Nye heterocykliske substituerede pyrrolidinamidderivater
NO975633L (no) Fremgangsmåte for syntese av vinylsulfensyrederivater
NO981655D0 (no) Fenantridin-derivater, fremgangsmÕter for fremstilling derav og medikamenter inneholdende fenantridin-derivater